The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.390
-0.100 (-6.71%)
At close: Nov 21, 2024, 4:00 PM
1.420
+0.030 (2.16%)
After-hours: Nov 21, 2024, 4:34 PM EST
The Beauty Health Company Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 173 | 408 | 1,203 | 3,615 | 633 | - | |
Market Cap Growth | -77.68% | -66.07% | -66.72% | 470.81% | - | - | |
Enterprise Value | 394 | 601 | 1,270 | 3,628 | 836 | - | |
Last Close Price | 1.49 | 3.11 | 9.10 | 24.16 | 11.31 | - | |
Forward PE | 13.90 | - | 47.05 | - | - | - | |
PS Ratio | 0.54 | 1.03 | 3.29 | 13.90 | 5.32 | - | |
PB Ratio | 3.10 | 6.87 | 7.20 | 11.96 | -21.14 | - | |
P/TBV Ratio | - | - | - | 29.49 | - | - | |
P/OCF Ratio | - | 18.77 | - | - | - | - | |
EV/Sales Ratio | 1.13 | 1.51 | 3.47 | 13.95 | 7.02 | - | |
Debt / Equity Ratio | 9.52 | 12.67 | 4.51 | 2.48 | -7.23 | -157.10 | |
Debt / EBITDA Ratio | - | - | 370.87 | - | - | 6.96 | |
Asset Turnover | 0.42 | 0.41 | 0.33 | 0.36 | 0.53 | - | |
Inventory Turnover | 2.32 | 2.42 | 1.62 | 2.79 | 2.43 | - | |
Quick Ratio | 5.35 | 5.16 | 9.09 | 12.47 | 1.06 | 0.82 | |
Current Ratio | 6.56 | 6.07 | 10.92 | 13.09 | 1.91 | 1.43 | |
Return on Equity (ROE) | -37.64% | -88.42% | 18.84% | -278.16% | - | - | |
Return on Assets (ROA) | -5.90% | -8.47% | -1.45% | -3.46% | -4.78% | - | |
Return on Capital (ROIC) | -6.71% | -9.45% | -1.64% | -4.03% | -5.73% | - | |
Earnings Yield | -15.93% | -24.52% | 3.68% | -10.48% | -4.61% | - | |
FCF Yield | -3.52% | -0.13% | -9.88% | -1.09% | -2.52% | - | |
Buyback Yield / Dilution | 6.82% | 11.33% | -45.43% | -197.77% | -6.71% | -65282.60% | |
Total Shareholder Return | 6.82% | 11.33% | -45.43% | -197.77% | -6.71% | -65282.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.